BioMarin Pharmaceutical Inc. buy Citigroup Inc.
Start price
19.05.26
/
50%
€42.91
Target price
19.05.27
€64.43
Performance (%)
34.09%
Price
10:24
€57.54
Summary
This prediction is currently active. With a performance of 34.09% the BUY prediction by Citigroup_Inc_ is a big success. This prediction currently runs until 19.05.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BioMarin Pharmaceutical Inc. | -3.950% | -3.950% |
| iShares Core DAX® | -0,87 % | 5,32 % |
| iShares Nasdaq 100 | -0,38 % | 1,98 % |
| iShares Nikkei 225® | -1,68 % | 1,95 % |
| iShares S&P 500 | -0,65 % | 2,07 % |
Comments by Citigroup_Inc_ for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical (BMRN) is now covered by Citigroup Inc.. They set a "buy" rating and a $75.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€51.44
16.07.26
16.07.26
€66.28
16.07.27
16.07.27
11.39%
10:24
10:24
